Pre-Operative Radiation Therapy for Breast Cancer
(SPORT-DS Trial)
Recruiting in Palo Alto (17 mi)
Age: 65+
Sex: Female
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Waitlist Available
Sponsor: Michael Yassa
No Placebo Group
Trial Summary
What is the purpose of this trial?
To study a single dose of preoperative partial radiotherapy to a low-risk breast tumour. The radiotherapy will be goven 3 months before surgery.
Research Team
Eligibility Criteria
This trial is for women aged 65 or older with low-risk breast cancer. Eligible participants have a small tumor (less than 2cm), no nodal disease, positive estrogen receptor status, negative Her2, and are planning partial mastectomy. Exclusions include prior cancers (except certain skin cancers), large tumors, lobular carcinoma only, positive lymph nodes, and serious non-cancer illnesses.Inclusion Criteria
You have had markers placed at the treatment site before starting the trial.
My breast cancer was confirmed by a biopsy within the last 3 months.
My tumor is smaller than 2cm according to a physical exam and ultrasound.
See 8 more
Exclusion Criteria
Psychiatric or addictive disorders which would preclude obtaining informed consent or adherence to protocol
I have had cancer before, but if it was skin cancer, it's okay.
I am under 65 years old.
See 19 more
Treatment Details
Interventions
- Single Pre-Operative Radiation Therapy - with Delayed Surgery (Radiation Therapy)
Trial OverviewThe study tests a single dose of preoperative partial radiotherapy given three months before surgery on patients with low-risk breast tumors. It aims to assess the effectiveness and safety of this approach compared to traditional treatment timelines.
Participant Groups
1Treatment groups
Experimental Treatment
Group I: Single Pre-Operative Radiation Therapy with Delayed SurgeryExperimental Treatment1 Intervention
Single Pre-Operative Radiation Therapy with Delayed Surgery
Find a Clinic Near You
Research Locations NearbySelect from list below to view details:
Maisonneuve-Rosemont HospitalMontreal, Canada
Loading ...
Who Is Running the Clinical Trial?
Michael Yassa
Lead Sponsor
Trials
1
Patients Recruited
20+